- Pfizer Inc.
- University of California, San Francisco
- Johnson & Johnson
- Bayer AG
- Icahn School of Medicine
- Rockefeller University
- New York University Medical Center
- Memorial Sloan Kettering Cancer Center
- New York-Presbyterian Hospital/Columbia University
- Yeshiva University
- Albert Einstein College of Medicine
- Cornell University
- AstraZeneca PLC
- MedImmune LLC
- Eli Lilly & Co.
- ImClone Systems Inc.
- Novartis AG
- Massachusetts General Hospital
- Harvard University
- Harvard Medical School
- Novartis Institutes for BioMedical Research Inc.
- California Institute of Technology
- Massachusetts Institute of Technology
- GlaxoSmithKline PLC
- Sanford Burnham Prebys Medical Discovery Institute
- Pentraxin Therapeutics Ltd.
- Pfizer acquires Wyeth in $67bn deal
- Pfizer, UCSF team up in broad research agreement
- Lilly comes out on top with $70/share ImClone bid
- J&J's Ortho-McNeil-Janssen Pharmaceuticals teams with Sanford-Burnham Medical Research Institute
- Bayer forms research collaborations with UCSF
- GSK partners with Pentraxin on amyloidosis treatment
- Sanofi and UCSF research cancer and other conditions
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.